[artículo] 
inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 575-584

Título :	Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia
Tipo de documento:	texto impreso
Autores:	Arija Maat, Autor ; Wiepke Cahn, Autor ; Harm J. Gijsman, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 575-584
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Aripiprazol, Neurocognición, Risperidona, Esquizofrenia, Cognición social
Resumen:	To date, only few studies have examined the impact of medication on social cognition and none have examined the effects of aripiprazole in this respect. The goal of this 8-week, randomized, multicenter, open-label study was to examine the effects of aripiprazole and risperidone on social cognition and neurocognition in individuals with schizophrenia.
Link:	./index.php?lvl=notice_display&id=26977

[artículo] Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia [texto impreso] / Arija Maat, Autor ; Wiepke Cahn, Autor ; Harm J. Gijsman, Autor . - 2021 . - pp. 575-584.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 575-584

Palabras clave:	Aripiprazol, Neurocognición, Risperidona, Esquizofrenia, Cognición social
Resumen:	To date, only few studies have examined the impact of medication on social cognition and none have examined the effects of aripiprazole in this respect. The goal of this 8-week, randomized, multicenter, open-label study was to examine the effects of aripiprazole and risperidone on social cognition and neurocognition in individuals with schizophrenia.
Link:	./index.php?lvl=notice_display&id=26977